Navigation Links
Window for Stroke Treatment Opens Wider
Date:5/28/2009

Clot-busting drug found effective 4.5 hours after symptoms begin

THURSDAY, May 28 (HealthDay News) -- A new analysis showing that a potent clot-dissolving drug can safely be used to treat strokes four-and-a-half hours after symptoms begin has prompted a change in a current recommendation, which set a three-hour deadline for the medication's use.

The review of 1,622 cases of people treated with tissue plasminogen activator (tPA) in four separate studies finds that the benefit in keeping brain cells alive outweighs the risk of brain-damaging bleeding when the drug is given up to 4.5 hours after first symptoms, according to a report in the May 28 online issue of Stroke. The most convincing results came from the latest study, in which 821 people were treated later than is currently recommended.

"By pooling data from four prior clinical trials in which patients were treated with tPA between three and four-and-a-half hours, we were able to demonstrate that treatment with tPA is beneficial even if it is started between three and four-and-a-half hours of symptom onset," said study author Dr. Maarten Lansberg, an assistant professor of neurology and neurological sciences at Stanford University.

An advisory committee of the American Stroke Association/American Heart Association (ASA/AHA) promptly issued a recommendation that the window for tPA therapy be opened that much wider; that advisory appears in the same issue of Stroke.

"The advisory updates the current guidelines to recommend treatment in select patients in the three- to four-and-a-half hour window, but urges confirmation of the trial's results with further analyses," according to a statement issued by the ASA/AHA.

"In practical terms, wide adoption of the recommendation would mean that 2 percent to 3 percent more people who suffer strokes caused by blockage of a brain artery would receive tPA therapy," said Dr. Jeffrey L. Saver, a
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Childrens Hospital Boston Deploys AutoVirt Solution to Increase Speed and Efficiency of Windows Data Replication
2. Microsoft Windows Embedded Announces Winner of SPARKs Will Fly Developer Contest
3. Newly Pregnant Smokers Have a 15-Week Window to Quit
4. New Survey Results Give a Window Into Teen Behavior and Risks
5. Stroke therapy window might be extended past nine hours for some
6. New Johns Hopkins imaging center to widen windows on the brain
7. Window World Cares Raises $160,000 for St. Jude Childrens Hospital, Commits to Ongoing Support
8. LSUHSC study finds high-dose HBO2 therapy extends survival window after cardiopulmonary arrest
9. CARDIA Studies Open Window on Heart, Lung Diseases
10. Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems
11. MRI: A window to genetic properties of brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Window for Stroke Treatment Opens Wider
Window for Stroke Treatment Opens Wider
Breaking Medicine Technology:Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Statins Might Stave Off Alzheimers 50433 1Statins Might Stave Off Alzheimers 50433 2Caregivers may benefit from adult day care 50428 1Caregivers may benefit from adult day care 50428 2Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 50425 1Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 50425 2Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 50425 3